Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02899754 · ClinicalTrials.gov registry record · NA
Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions
A NA study of Lung Cancer Screening, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 3
- Study locations
NCT02899754 is a NA study of Lung Cancer Screening that has completed, run by VA Office of Research and Development. The registered enrollment target is 140 participants, below the 509-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (72% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT02899754, a NA study of Lung Cancer Screening, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 3
- Study locations
Study Summary
Veterans have a high risk of developing lung in comparison to general populations due to their older age and smoking history. Recent evidence indicates that lung cancer screening with low dose CT scan reduces lung cancer mortality among older heavy smokers. However, the rates of false positive findings are high, requiring further testing and evaluation. The aims of this study were to 1) elicit patient and provider stakeholder input to inform the development of a lung cancer screening decision tool, 2) develop a web-based Lung Cancer Screening Decision Tool (LCSDecTool) that incorporates patient and provider input, and 3) conduct a RCT to evaluate LCSDecTool compared to usual care knowledge about LCS, decisional conflict and uptake of LCS. The investigators hypothesized that the use of the LCSDecTool would decrease decisional conflict at 1 month. As a secondary outcome the investigators hypothesized that there would be a decrease in uptake of LCS in the LCDDecTool group compared with the control intervention due to increased awareness of harms associated with LCS. Additional secondary outcomes were LCS knowledge, decisional regret, anxiety, and lung cancer worry. Veterans who were receiving primary care in a participating VA Medical Center, aged 55 to 80 years with a smoking history of at least 30 pack-years who were current smokers or had quit within the past 15 years were eligible to participate in the study. Participants were asked to link on to a study website and were randomly assigned to the LCSDecTool or a control intervention website. Following use of the intervention, participants had a primary care visit. Patient reported outcomes were assessed immediately post intervention and at 1 and 3-months post intervention. LCS uptake was assessed at 6 months post-intervention.
Conditions Studied
Interventions
- BEHAVIORAL Control Intervention
- BEHAVIORAL Lung Cancer Screening Decision Tool
Study Locations (3)
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Pennsylvania
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA - Philadelphia
Wisconsin
- Clement J. Zablocki VA Medical Center, Milwaukee, WI - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2019-01-28 |
| Est. Completion | 2021-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02899754
The ClinicalTrials.gov registry entry for NCT02899754 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 509-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (72% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which Control Intervention is the first listed.
NCT02899754 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Pennsylvania, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT02899754 about?
NCT02899754 is a clinical study titled "Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions". Veterans have a high risk of developing lung in comparison to general populations due to their older age and smoking history. Recent evidence indicates that lung cancer screening with low dose CT scan reduces lung cancer mortality among older heavy smokers. However, the rates of false positive findi...
What is the current status of trial NCT02899754?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2019-01-28. Estimated completion is 2021-11-30.
What conditions does trial NCT02899754 study?
This clinical trial studies the following conditions: Lung Cancer Screening.
What interventions are being tested in trial NCT02899754?
The interventions under investigation include: Control Intervention (BEHAVIORAL), Lung Cancer Screening Decision Tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT02899754?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02899754 being conducted?
This trial has 3 study locations across Connecticut, Pennsylvania, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Lung Cancer Screening One Text at a Time
RECRUITING · NA
-
Digitally Enhanced Smoking Cessation for High Risk Smokers
ACTIVE NOT RECRUITING · NA
-
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
ACTIVE NOT RECRUITING · NA
-
The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
COMPLETED · NA
-
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
RECRUITING
-
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.